Nonetheless, few investigations in recent decades have searched for mutations in other genes, such as CDKN2A, PTEN and AKT1, which could provide more knowledge regarding this tumor’s resistance and etiopathogenesis. This evidence concerns the gene PTEN and neoplasm.